European Commission Approves Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a ...
2 Stocks to Buy if You're Worried About a Recession
Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies. Though things ...
StockStory.org on MSN8h
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Navigating Potential Recession: 3 Stocks to Consider
Utility stocks are often considered a safe haven during economic troubles, and Dominion Energy (NYSE: D) stands out as a prime candidate. With a substantial customer base of 3.6 million in Virginia, ...
Should You Invest in the iShares Biotechnology ETF (IBB)?
You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05/2001. An increasingly popular option among retail and institutional investors, ...
Vertex's Journavx Launch Sparks Optimism, Analyst Sees 'Two Potential Upside Levers'
Vertex Pharmaceuticals sees early success with Journavx painkiller, potential revenue growth from drug and gene therapy.
GlobalData on MSN9h
Global Tactical Metals agrees to acquire Critical Defense Metals
The transaction is expected to close by 30 April 2025, pending customary closing conditions and regulatory approvals.
Tuko on MSN9h
'Everyone is losing money': Hong Kong investors rattled by market rout
Hong Kong small-time investors were left reeling on Monday as US President Donald Trump's punishing tariffs and Beijing's ...